T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.
about
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemyDiagnosis of Bloodstream Infections in ChildrenT2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasisPortable devices and mobile instruments for infectious diseases point-of-care testing.Intensive care medicine research agenda on invasive fungal infection in critically ill patients.Prophylactic Measures During Induction for Acute Myeloid Leukemia.A Review of Diagnostic Methods for Invasive Fungal Diseases: Challenges and Perspectives.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Recent Progress in the Diagnosis of Pathogenic Candida Species in Blood Culture.Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance.A dedicated fungal culture medium is useful in the diagnosis of fungemia: a retrospective cross-sectional studyMolecular diagnosis of invasive mycoses of the central nervous system.Cost-Effectiveness Analysis of Multiplex PCR with Magnetic Resonance Detection versus Empiric or Blood Culture-Directed Therapy for Management of Suspected Candidemia.Duplex DNA-Invading γ-Modified Peptide Nucleic Acids Enable Rapid Identification of Bloodstream Infections in Whole Blood.Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid DiagnosticsA Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole BloodThe Emergency Care of Patients With Cancer: Setting the Research Agenda.Advances in Candida detection platforms for clinical and point-of-care applicationsDelivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic CapabilitiesAntifungal stewardship in daily practice and health economic implications.Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Invasive candidiasis: future directions in non-culture based diagnosis.Advances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls.Microarray Technologies in Fungal Diagnostics.PCR methodology and applications for the detection of human fungal pathogens.Diagnostic of Fungal Infections Related to Biofilms.Antifungal stewardship considerations for adults and pediatrics.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.The economic impact of rapid Candida species identification by T2Candida among high-risk patients.Implementation of Rapid Molecular Infectious Disease Diagnostics: the Role of Diagnostic and Antimicrobial StewardshipDiagnosis, classification, and therapeutic interventions for sinopulmonary Aspergillosis.MASTERMIND: Bringing Microbial Diagnostics to the Clinic.Nucleic acid amplification methodologies for the detection of pulmonary mold infections.The current treatment landscape: the need for antifungal stewardship programmes.Progress in the Diagnosis of Invasive Fungal Disease in Children.T2Candida Provides Rapid and Accurate Species Identification in Pediatric Cases of Candidemia.Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.Future Research Priorities in Fungal Resistance.
P2860
Q26745677-4E466522-5981-4886-BA69-E9FA6E4B215CQ28071821-5B5E129B-A074-42D1-9AAC-E6F2DBF2FD9DQ28084998-7702B9D2-C684-407B-B422-FA3F7BF973CAQ30235078-012F4CE3-A99C-473B-9176-5C3D5056043DQ30235457-EFADB228-16EE-4433-9D75-5D3B10A5A896Q30235496-878EF0F2-39D7-4E75-BC36-325CE239BC3EQ33732549-73AA4F19-84F4-46EF-8257-983CFFA69C4FQ34505582-DA43AD36-4276-4214-A465-5B32170AEBA1Q35966202-75B07357-9F9F-4AED-8C42-6DAE4C5241C2Q35997535-CDBB0B16-1A4B-46A6-AE07-E121EEBB2BF0Q36162773-3BACDAA0-8729-4553-8B11-3E7845168FEAQ36218994-D595BA1A-A8FF-475A-841D-ACD0F7CD7856Q36620896-5018E7E5-BF22-4DAF-A5B7-5FA76E406D57Q36849914-37A502FD-5EE5-40EC-A4B3-542CC2303DB4Q37087480-F5A0A722-6D82-4D04-8107-CEAD39430B0EQ37149965-3DCB3E02-B197-4F9A-8ACF-ED461BC73B3AQ37211558-82897160-2A52-4CDF-BA43-6ED33DF5AA15Q37372500-77F863C2-D5C7-4905-AF83-3C77842ACCA4Q37664419-A40CD65D-DFB6-4395-A72F-1E8BE3F7B666Q38511950-E1944E9C-B7B5-4653-B1FE-01A2FAFDE896Q38531765-094895EC-B074-4846-8173-E5D1AB231FDDQ38535647-300631B3-3BF5-4DFD-AAC9-D951FF74D3CEQ38589279-AE4F3DF4-7AD7-4119-8A71-DD67D0ADB8DBQ38614492-EF94447E-3A9D-4E9F-891D-17ECCB0772B9Q38637507-B0FF338C-E684-4BD1-8DE0-4974C9B206D4Q38796137-766BA2F5-9221-4A49-9BDF-C08280E37B7BQ38835204-0A032018-487E-41B0-9692-720105A1C97EQ38853348-35605D21-E8BB-4583-B982-E3D6818922DAQ38944746-C74D4B7F-E0B6-42E1-A0D1-C98824D51B16Q38965488-2D2CCCF3-B5E0-439D-B59C-9833F71F80DEQ39020917-4357AC03-4C2F-464A-A73D-92CDFC0EDFDCQ39061539-F1745748-8582-48A4-9B86-6ACDADA7173DQ39091924-493382F5-81C3-4BA8-A8C6-76469BBB3F4EQ39121779-D5471D24-1E1E-4D8E-9A9C-EA25C3F06238Q39144117-88F6CB0A-255A-43C0-9DC4-64C15AD3DD04Q39158684-535FBA0C-1792-4EB0-B8E3-68985C613C2AQ39416559-6781D017-3E5A-4337-ACA5-128D58692FF6Q39719944-B1C37833-70FC-49C0-A06D-796C3CAE74B7Q40045673-BF0D6AB3-B805-4D9F-9E17-AD4DA5E3A54AQ40045680-9BBE6A7A-BCEF-44F5-B934-BF0616F71D0D
P2860
T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
T2 magnetic resonance assay fo ...... whole blood: a clinical trial.
@en
type
label
T2 magnetic resonance assay fo ...... whole blood: a clinical trial.
@en
prefLabel
T2 magnetic resonance assay fo ...... whole blood: a clinical trial.
@en
P2093
P2860
P356
P1476
T2 magnetic resonance assay fo ...... whole blood: a clinical trial.
@en
P2093
Cornelius J Clancy
Dimitrios P Kontoyiannis
Eleftherios Mylonakis
Fainareti N Zervou
George J Alangaden
Ioannis M Zacharioudakis
Jeffrey S Groeger
Jose A Vazquez
Kevin W Garey
Luis Ostrosky-Zeichner
P2860
P304
P356
10.1093/CID/CIU959
P407
P577
2015-01-12T00:00:00Z